Anzeige
Mehr »
Login
Mittwoch, 05.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Geheime Erdgas-Perle: Horizon Petroleum startet Lachowice-Projekt: Aktie vor neuem Höhenflug?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
502 Leser
Artikel bewerten:
(0)

Argon Medical Devices Acquires Mana-Tech, Ltd.

Finanznachrichten News

FRISCO, Texas, May 30, 2019 /PRNewswire/ -- Argon Medical Devices, Inc., a global manufacturer of specialty medical devices used in interventional procedures, announced today that it has completed the acquisition of Mana-Tech, Ltd., its exclusive distributor for the United Kingdom and Ireland.

Argon Medical Devices, Inc. Logo.

For more information on Argon Medical's products & services visit www.argonmedical.com.

"The acquisition of Mana-Tech, Ltd. represents a compelling growth opportunity to expand our commercial reach in the UK, Ireland and throughout Europe," George Leondis, President and Chief Executive Officer of Argon Medical Devices, commented. "We are excited to have this very talented group join Argon and to work even more closely with them to continue their successful growth trajectory."

The entire Mana-Tech team, including its management, sales, customer service and distribution groups, will join Argon as part of the acquisition.

About Argon Medical Devices

Argon Medical Devices, Inc., based in Frisco, TX, is a global manufacturer of specialty medical devices, used in Interventional procedures. Argon offers a broad line of disposable medical devices for Interventional Radiology, Interventional Oncology and Vascular Surgery. Argon's brand is recognized for best-in-class products that improve patient outcomes via percutaneous, image-guided procedures.

Logo - https://mma.prnewswire.com/media/319111/argon_medical_devices_inc_logo.jpg

© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.